Clinical Trial Update: Safety and Efficacy Study of Intravenous Uricase-PEG 20 [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety and preliminary efficacy of intravenous Uricase-PEG 20 for treating gout and hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Uricase-PEG 20 (uricase-peg-20)

Snippet

Sponsor: EnzymeRx | Conditions: Gout, Hyperuricemia | Phase 1 | Status: UNKNOWN